| mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
4e-10 |
| mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
1e-08 |
| mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-07 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-06 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-06 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
4e-06 |
| mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
4e-06 |
| mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
7e-06 |
| mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
8e-06 |
| mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
1e-05 |